The present invention provides new compounds displaying antiglutamatergic properties. It also provides the use of such compounds for the treatment and/or prophylaxis of conditions and diseases linked to abnormalities in glutamatergic transmission. It further provides a pharmaceutical composition for the treatment and/or prophylaxis of acute and chronic neurodegenerative conditions and disorders.
本发明提供了显示抗谷
氨酸作用的新化合物。它还提供了利用这些化合物治疗和/或预防与谷
氨酸传递异常相关的疾病和疾病的用途。此外,还提供了用于治疗和/或预防急性和慢性神经退行性疾病和疾病的药物组合物。